Identifying two pathways to poor prognosis in patients with anti-MDA5 antibodies: insights from prognostic factor and cytokines analysis
Two pathways leading to poor prognosis were identified in anti-MDA5-Ab-positive patients, each marked by specific cytokine abnormalities.
Authors
- Tomoyuki Miyao (ORCID: https://orcid.org/0000-0002-8769-2702)
- Yoshiaki Yoshida (ORCID: https://orcid.org/0000-0003-2232-7533)
- Kazuhiro Kurasawa (ORCID: https://orcid.org/0000-0001-6024-7556)
- Anna Hasegawa
- Azusa Kikuchi (ORCID: https://orcid.org/0000-0002-0530-3161)
- Masafumi Arima (ORCID: https://orcid.org/0000-0002-5169-7536)
- Satoko Arai (ORCID: https://orcid.org/0000-0002-6145-8686)
- Reika Maezawa
- Aya Shimizu
- Tomoka Hiyama
- Kei Ikeda (ORCID: https://orcid.org/0000-0003-0574-9611)
- Sara Komatsu
- Ayae Tanaka
Institutions
- Dokkyo Medical University (JP)
Publication Details
- Journal
- Arthritis Research & Therapy
- Published
- 2025-04-16
- DOI
- https://doi.org/10.1186/s13075-025-03558-z
- Citations
- 1
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Japan Society for the Promotion of Science